489 related articles for article (PubMed ID: 30499104)
1. MED28 and forkhead box M1 (FOXM1) mediate matrix metalloproteinase 2 (MMP2)-dependent cellular migration in human nonsmall cell lung cancer (NSCLC) cells.
Hsieh NT; Huang CY; Li CC; Wang IC; Lee MF
J Cell Physiol; 2019 Jul; 234(7):11265-11275. PubMed ID: 30499104
[TBL] [Abstract][Full Text] [Related]
2. MED28 regulates MEK1-dependent cellular migration in human breast cancer cells.
Huang CY; Chou YH; Hsieh NT; Chen HH; Lee MF
J Cell Physiol; 2012 Dec; 227(12):3820-7. PubMed ID: 22495818
[TBL] [Abstract][Full Text] [Related]
3. miR-149 suppresses human non-small cell lung cancer growth and metastasis by inhibiting the FOXM1/cyclin D1/MMP2 axis.
Zhao L; Liu L; Dong Z; Xiong J
Oncol Rep; 2017 Dec; 38(6):3522-3530. PubMed ID: 29130108
[TBL] [Abstract][Full Text] [Related]
4. FoxM1 affects adhesive, migratory, and invasive abilities of human retinoblastoma Y-79 cells by targeting matrix metalloproteinase 2.
Zhu X; Yu M; Wang K; Zou W; Zhu L
Acta Biochim Biophys Sin (Shanghai); 2020 Mar; 52(3):294-301. PubMed ID: 32152631
[TBL] [Abstract][Full Text] [Related]
5. [Role of inhibition of transcription factor forkhead box M1 expression by RNA interference in the proliferation and invasiveness of non-small cell lung cancer cells].
Zhou L; Zhang PH; Xu X; Xu N; Gao L; Bai CX; Zhang X
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(34):2424-8. PubMed ID: 20137699
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of FoxM1 by MnSOD Overexpression Contributes to Cancer Stem-Like Cell Characteristics in the Lung Cancer H460 Cell Line.
Fu Z; Cao X; Yang Y; Song Z; Zhang J; Wang Z
Technol Cancer Res Treat; 2018 Jan; 17():1533033818789635. PubMed ID: 30111255
[TBL] [Abstract][Full Text] [Related]
7. MnSOD promotes tumor invasion via upregulation of FoxM1-MMP2 axis and related with poor survival and relapse in lung adenocarcinomas.
Chen PM; Wu TC; Shieh SH; Wu YH; Li MC; Sheu GT; Cheng YW; Chen CY; Lee H
Mol Cancer Res; 2013 Mar; 11(3):261-71. PubMed ID: 23271813
[TBL] [Abstract][Full Text] [Related]
8. FOXM1 regulated by ERK pathway mediates TGF-β1-induced EMT in NSCLC.
Kong FF; Zhu YL; Yuan HH; Wang JY; Zhao M; Gong XD; Liu F; Zhang WY; Wang CR; Jiang B
Oncol Res; 2014; 22(1):29-37. PubMed ID: 25700356
[TBL] [Abstract][Full Text] [Related]
9. Highly expressed lncRNA FOXD3-AS1 promotes non-small cell lung cancer progression via regulating miR-127-3p/mediator complex subunit 28 axis.
Zeng ZL; Zhu HK; He LF; Xu X; Xie A; Zheng EK; Ni JJ; Liu JT; Zhao GF
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2525-2538. PubMed ID: 32196603
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of 14-3-3γ Suppresses Epithelial-Mesenchymal Transition and Reduces Metastatic Potential of Human Non-small Cell Lung Cancer Cells.
Raungrut P; Wongkotsila A; Champoochana N; Lirdprapamongkol K; Svasti J; Thongsuksai P
Anticancer Res; 2018 Jun; 38(6):3507-3514. PubMed ID: 29848704
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells.
Wang Z; Banerjee S; Kong D; Li Y; Sarkar FH
Cancer Res; 2007 Sep; 67(17):8293-300. PubMed ID: 17804744
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of ZNF746 suppresses invasion and epithelial to mesenchymal transition in H460 non-small cell lung cancer cells.
Kim B; Sohn EJ; Jung JH; Shin EA; You OH; Im J; Kim SH
Oncol Rep; 2014 Jan; 31(1):73-8. PubMed ID: 24145959
[TBL] [Abstract][Full Text] [Related]
13. The Tumor Suppressive Role of MiRNA-509-5p by Targeting FOXM1 in Non-Small Cell Lung Cancer.
Ma N; Zhang W; Qiao C; Luo H; Zhang X; Liu D; Zang S; Zhang L; Bai J
Cell Physiol Biochem; 2016; 38(4):1435-46. PubMed ID: 27035590
[TBL] [Abstract][Full Text] [Related]
14. Propofol Inhibits Lung Cancer A549 Cell Growth and Epithelial-Mesenchymal Transition Process by Upregulation of MicroRNA-1284.
Liu WZ; Liu N
Oncol Res; 2018 Dec; 27(1):1-8. PubMed ID: 29402342
[TBL] [Abstract][Full Text] [Related]
15. Sestrin2 mediates FOXM1 expression to block the EMT process in non-small cell lung cancer through the AMPK/YAP pathway.
Wang YL; Wang Q; Li H; Wang CC; Ma YL; Han Z
Neoplasma; 2023 Feb; 70(1):46-57. PubMed ID: 36620877
[TBL] [Abstract][Full Text] [Related]
16. miR-134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non-small cell lung cancer cells.
Li J; Wang Y; Luo J; Fu Z; Ying J; Yu Y; Yu W
FEBS Lett; 2012 Oct; 586(20):3761-5. PubMed ID: 23010597
[TBL] [Abstract][Full Text] [Related]
17. The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer.
Kim IM; Ackerson T; Ramakrishna S; Tretiakova M; Wang IC; Kalin TV; Major ML; Gusarova GA; Yoder HM; Costa RH; Kalinichenko VV
Cancer Res; 2006 Feb; 66(4):2153-61. PubMed ID: 16489016
[TBL] [Abstract][Full Text] [Related]
18. CSN5 promotes the invasion and metastasis of pancreatic cancer by stabilization of FOXM1.
Mao L; Le S; Jin X; Liu G; Chen J; Hu J
Exp Cell Res; 2019 Jan; 374(2):274-281. PubMed ID: 30352219
[TBL] [Abstract][Full Text] [Related]
19. Propofol suppresses LPS-induced nuclear accumulation of HIF-1α and tumor aggressiveness in non-small cell lung cancer.
Yang N; Liang Y; Yang P; Ji F
Oncol Rep; 2017 May; 37(5):2611-2619. PubMed ID: 28426124
[TBL] [Abstract][Full Text] [Related]
20. Targeting FoxM1 inhibits proliferation, invasion and migration of nasopharyngeal carcinoma through the epithelial‑to-mesenchymal transition pathway.
Yu C; Chen L; Yie L; Wei L; Wen T; Liu Y; Chen H
Oncol Rep; 2015 May; 33(5):2402-10. PubMed ID: 25738652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
